%PDF-1.4
2 0 obj
<>endobj
3 0 obj
<>
endobj
4 0 obj
<>
endobj
5 0 obj
<>stream
uuid:02176603-20e4-45b9-81a1-583eb6616085
adobe:docid:indd:2efc58b4-c311-11e0-a7ff-fa5dedf44eed
xmp.id:13d7b11c-e0c5-ae49-9668-0a5ab4ab2e61
proof:pdf
xmp.iid:1df138f2-09f1-7046-8fa5-6b7c07419b94
xmp.did:B1F016B06396E4119934F53B4CBBE186
adobe:docid:indd:2efc58b4-c311-11e0-a7ff-fa5dedf44eed
default
converted
from application/x-indesign to application/pdf
Adobe InDesign 16.3 (Windows)
/
2021-08-31T12:53:07+05:30
2021-08-31T12:53:07+05:30
2021-09-14T17:58:21+05:30
2021-09-14T17:58:21+05:30
Adobe InDesign 16.3 (Windows)
application/pdf
A Pilot Study of Nemonoxacin in Patients with Diabetic Foot Infections
Ming-Chu Hsue
Nemonoxacin
Diabetic foot infections
DFI
Fluoroquinolone
Efficacy
Safety
Journal of Infectious Diseases & Therapy
2.2.19 (4.2.6)
False
endstream
endobj
6 0 obj
<>endobj
7 0 obj
<>
endobj
8 0 obj
<>
endobj
9 0 obj
<>
endobj
10 0 obj
<>/Font <>/ProcSet [/PDF /Text ]/XObject <>>>/Rotate 0 /StructParents 0 /TrimBox [0 0 595.3 841.9 ]/Type /Page >>endobj
11 0 obj
<>/ExtGState <>/Font <>/ProcSet [/PDF /Text /ImageC /ImageI ]/XObject <>>>/Rotate 0 /StructParents 1 /TrimBox [0 0 595.3 841.9 ]/Type /Page >>endobj
12 0 obj
<>endobj
13 0 obj
<>endobj
14 0 obj
<>/ExtGState <>/Font <>/ProcSet [/PDF /Text /ImageC /ImageI ]/XObject <>>>/Rotate 0 /StructParents 6 /TrimBox [0 0 595.3 841.9 ]/Type /Page >>endobj
15 0 obj
<>endobj
16 0 obj
<>endobj
17 0 obj
<>
endobj
18 0 obj
<>
endobj
19 0 obj
<>
endobj
20 0 obj
<>
endobj
21 0 obj
<>/Font<>>>
endobj
22 0 obj
<>stream
HWmo"7ίG(RHk{GRUP#,;wk8"v~<3:cF##Oί3Ŕt'q?z0r?xz$A;j"91(7H1&cRo?U>M|89.9UX=a.T0Ur 'p/q~xkT!q
}|qWF^{Jٗ0GK178e*F<7Gڑ1P ?kpDFX8֔!ߏ/-eRBʏBefY][B:;ޭ_/z đ-I%z5B((ЄR+poD&7LR{Cz*}X̶w+}kjGsgICux;bT
p!z; ~v
8(ju"6`NY#ٷeAM(G
8[y.{$&/v8S.W>-i Z5Gv$D+ƚkde 7dLZ6jpNZ&6ISM9J0+r?uZIT NQMUN;q$@WZC73/ͧs/كQ݇A%BSIvu7G~͓yeuƢڿV)$pV]9ǫsN8WMŕ sy4+BQo
n)UtBia)AMy᷉Ѷm-@IR$&)
8e=ܵTL&[2<IIRr,!B:t7lX⸳˴*)7 TZM9g !WN&TߔFI~EuMJUBR!PS> 1>$Evٰڳ!ʭ*5F.4ܞ+&ݰ;ܲ϶I